...
首页> 外文期刊>BioMed research international >Novel Design Strategy for Checkpoint Kinase 2 Inhibitors Using Pharmacophore Modeling, Combinatorial Fusion, and Virtual Screening
【24h】

Novel Design Strategy for Checkpoint Kinase 2 Inhibitors Using Pharmacophore Modeling, Combinatorial Fusion, and Virtual Screening

机译:药理学模型,组合融合和虚拟筛选的检查点激酶2抑制剂的新型设计策略。

获取原文
           

摘要

Checkpoint kinase 2 (Chk2) has a great effect on DNA-damage and plays an important role in response to DNA double-strand breaks and related lesions. In this study, we will concentrate on Chk2 and the purpose is to find the potential inhibitors by the pharmacophore hypotheses (PhModels), combinatorial fusion, and virtual screening techniques. Applying combinatorial fusion into PhModels and virtual screening techniques is a novel design strategy for drug design. We used combinatorial fusion to analyze the prediction results and then obtained the best correlation coefficient of the testing set (rtest) with the value 0.816 by combining theBesttrainBesttestandFasttrainFasttestprediction results. The potential inhibitors were selected from NCI database by screening according toBesttrainBesttest+FasttrainFasttestprediction results and molecular docking with CDOCKER docking program. Finally, the selected compounds have high interaction energy between a ligand and a receptor. Through these approaches, 23 potential inhibitors for Chk2 are retrieved for further study.
机译:Checkpoint激酶2(Chk2)对DNA损伤有很大作用,并且在对DNA双链断裂和相关损伤的反应中起重要作用。在这项研究中,我们将专注于Chk2,目的是通过药效基团假说(PhModels),组合融合和虚拟筛选技术找到潜在的抑制剂。将组合融合应用于PhModels和虚拟筛选技术是药物设计的一种新颖设计策略。我们使用组合融合来分析预测结果,然后通过结合BesttrainBesttest和FasttrainFasttest预测结果获得测试集的最佳相关系数(rtest),值为0.816。根据BesttrainBesttest + FasttrainFasttest的预测结果进行筛选,并通过CDOCKER对接程序进行分子对接,从NCI数据库中选择潜在的抑制剂。最后,所选化合物在配体和受体之间具有高相互作用能。通过这些方法,获得了23种潜在的Chk2抑制剂,以供进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号